Navigation Links
Acella Pharmaceuticals Announces a New Addition to the Commercial Team
Date:5/1/2012

ATLANTA, May 1, 2012 /PRNewswire/ -- Atlanta-based Acella Pharmaceuticals, LLC, announces the addition of Tom Larkin as Vice President of Sales and Marketing of their commercial team. Tom will lead the commercial sales and marketing organization for Acella's product line.   

Tom is a highly accomplished, entrepreneurial Sales & Marketing Executive, bringing more than 11 years of industry experience, including sales, marketing and managed-care experience, to Acella. He has built and led commercial sales teams at The Harvard Drug Group that delivered significant increases in revenue under his leadership.  In addition, his commercial team managed a product portfolio of more than 800 products under the Major Pharmaceuticals label. Tom holds a Bachelor of Arts Degree in Finance from Florida Atlantic University.

"We are extremely excited to add a person of Tom's talent to our commercial organization," said Mark Pugh, CEO of ACELLA.  "He will be of incredible value to the company as we continue to execute on delivering high-quality, affordable products to market."

About Acella Pharmaceuticals, LLC.

Acella develops, markets, sells and distributes a broad portfolio of non-branded pharmaceutical and other products in the areas of Dermatology, Women's Health, Pediatrics and other applications. Acella specializes in identifying and bringing to market quality, affordable products to customers and patients. For additional information please contact Acella at 678-325-5189.


'/>"/>
SOURCE Acella Pharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Acella Pharmaceuticals, LLC, Files Abbreviated New Drug Application (ANDA) With the U.S. Food & Drug Administration
2. Acella Pharmaceuticals, LLC Announces Its Acquisition of the PRENATE® Family of Trademarks and Associated Intellectual Property
3. Brookstone Pharmaceuticals, LLC becomes Acella Pharmaceuticals, LLC
4. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Second Quarter Financial Results And Conference Call
5. MAP Pharmaceuticals to Present at Upcoming Investor Conferences
6. Avanir Pharmaceuticals To Present at Three Conferences In May
7. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
8. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
9. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
10. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... -- Center Point Clinical Services, creator of ... today study results presented in two separate posters at ... and Specialty Pharmacy annual meeting in ... demonstrated that pharmacist-led patient interventions during clinical studies enhance ... crucial to generating the robust and high quality study ...
(Date:3/28/2017)... France and TEL AVIV, Israel , ... a subsidiary in Israel . This new business ... will be mostly dedicated to research and development of novel assays ... Ltd will also, when relevant, locally support commercialization and sales development ... ...
(Date:3/28/2017)... FRANCISCO , March 28, 2017 ...  is expected to reach a value of USD 4.5 ... Grand View Research, Inc. Proper closure of injured tissues ... structure and function. Postoperative leakages occur in 3% to ... complication. They are responsible for one third of postoperative ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... Usually, the impending arrival of ... However, for those self-conscious about a double chin, this means more anxiety than elation. ... , “For most people, a double chin is undesirable,” Dr. Goldman said, “but ...
(Date:3/28/2017)... ... March 28, 2017 , ... Award-winning medical group Allied ... as new board chair for Orange County health care system CalOptima Friday. CalOptima ... soon-to-be former chair Mark Refowitz’s term, which runs through June 30 of this ...
(Date:3/28/2017)... ... , ... With less than 10,000 dermatologists in the United States and more ... while the desire to conquer breakouts and eliminate skincare stress is widespread. Curology ... today released its inaugural survey on the State of Acne in America. , ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... The Executives, ... to raise money to for the Toys for Tots Literacy Campaign at their Semi-Annual ... in excess of $70 billion, the U.S. ranks at number 14 internationally in literacy. ...
(Date:3/28/2017)... CA (PRWEB) , ... March 28, 2017 , ... ... which will be offered by the American Association of Integrative Medicine and available ... for healthcare providers at the AutismOne 2017 Conference in Colorado Springs. , Ed ...
Breaking Medicine News(10 mins):